Skip to content

Food and Drug Recall.org

The Latest Food & Drug Recall and Safety News

FDA approves Erbitux to treat late-stage head and neck cancer

November 7, 2011Drug Recalls & Safety Notices, Drug Safety Information Podcasts, Food & Drug Recalls, Food Safety Newsadmin

The U.S. Food and Drug Administration today approved Erbitux (cetuximab) for use with chemotherapy to treat patients with late-stage (metastatic) head and neck cancer.

Post navigation

← Quirch Foods Co. Issues Alert on Uneviscerated Salted Smoked Split Herring, Packed in 18lb Wooden Boxes, Due to Possible Clostridium Botulinum Health Risk FDA launches website on safe disposal of used needles and other “sharps” →
Proudly powered by WordPress